The authors also detected a positive correlation between ghrelin and BNP levels and showed that these two peptides are colocalized in the myocardium, suggesting that in valvular heart disease, in the subclinical stage, the deficiency of endocrine signaling may be an important key factor that drives myocardial dysfunction. The gene discussed is NPPB; the disease is heart valve disorder.